Defective CD19-dependent signaling in B-1a and B-1b B lymphocyte subpopulations

Molecular Immunology

Volumn 39, Issue 1-2, 2002, Pages 57-68

  Sen, Goutam ^a,b,c   Wu, Hsin Jung ^a,b   Bikah, Gabriel ^a,b,d   Venkataraman, Chandrasekar ^a,b,e   Robertson, Darrell A ^a,b   Snow, E Charles ^a   Bondada, Subbarao ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d GLAXOSMITHKLINE   (United States)

^e AMGEN INC   (United States)

Author keywords

Autoimmunity; B 1 cells; BCR; CD19; Vav

Indexed keywords

B LYMPHOCYTE RECEPTOR; CALCIUM; CD19 ANTIGEN; IMMUNOGLOBULIN M; ISOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE LYN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; VAV PROTEIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CALCIUM MOBILIZATION; CELL LEVEL; CONTROLLED STUDY; CROSS LINKING; GENE AMPLIFICATION; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SPLEEN CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIGENS, CD19; B-LYMPHOCYTE SUBSETS; CALCIUM; CELL CYCLE PROTEINS; IMMUNOGLOBULIN M; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-VAV; RECEPTORS, ANTIGEN, B-CELL; TYROSINE;

EID: 0037105295     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(02)00047-0     Document Type: Article

References (50)

1. Arnold L.W., McCray S.K., Tatu C., Clarke S.H. Identification of a precursor phosphatidyl choline-specific B-1 cells suggesting that B-1 cells differentiate from splenic conventional B cells in vivo: cyclosporin A blocks differentiation to B-1. J. Immunol. 164:2000;2924-2930.
2. Bachmann M.F., Nitschke L., Krawczyk C., Tedford K., Ohashi P.S., Fischer K.D., Penninger J.M. The guanine-nucleotide exchange factor Vav is a crucial regulator of B cell receptor activation and B cell responses to non-repetitive antigens. J. Immunol. 163:1999;137-142.
3. Bikah G., Carey J., Ciallella J.R., Tarakhovsky A., Bondada S. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science. 274:1996;1906-1909.
4. Buhl A.M., Cambier J.C. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase. J. Immunol. 162:1999;4438-4446.
5. Caligaris-Cappio F., Gobbi M., Bofill M., Janossy G. Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J. Exp. Med. 155:1982;623-628.
6. Cambier J.C., Pleiman C.M., Clark M.R. Signal transduction by the B cell antigen receptor and its coreceptors. Annu. Rev. Immunol. 12:1994;457-486.
7. Carter R.H., Fearon D.T. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science. 256:1992;105-107.
8. Carter R.H., Tuveson D.A., Park D.J., Rhee S.G., Fearon D.T. The CD19 complex of B lymphocytes: activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex. J. Immunol. 147:1991;3663-3671.
9. Cherukuri A., Cheng P.C., Sohn H.W., Pierce S.K. The CD19-CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts. Immunity. 14:2001;169-719.
10. Chumley M.J., Dal Porto J.M., Kawaguchi S., Cambier J.C., Nemazee D., Hardy R.R. A VH11Vκ9 B cell antigen receptor drives generation of CD5+ B cells both in vivo and in vitro. J. Immunol. 164:2000;4586-4593.
11. Cong Y.Z., Rabin E., Wortis H.H. Treatment of murine CD5-B cells with anti-Ig, but not LPS, induces surface CD5: two B cell activation pathways. Int. Immunol. 3:1991;467-476.
12. De Fougerolles A.R., Batista F., Johnsson E., Fearon D.T. IgM and stromal cell-associated heparan sulfate/heparin as complement-independent ligands for CD19. Eur. J. Immunol. 31:2001;2189-2199.
13. DeFranco A.L. Vav and the B cell signalosome. Nat. Immunol. 2:2001;482-484.
14. Dempsey P.W., Allison M.E., Akkaraju S., Goodnow C.C., Fearon D.T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science. 271:1996;348-350.
15. Doody G.M., Billadeau D.D., Clayton E., Hutchings A., Berland R., McAdam S., Leibson P.J., Turner M. Vav-2 controls NFAT-dependent transcription in B- but not T-lymphocytes. EMBO J. 19:2000;6173-6184.
16. Doody G.M., Bell S.E., Vigorito E., Clayton E., McAdam S., Tooze R., Fernandez C., Lee I.J., Turner M. Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation. Nat. Immunol. 2:2001;542-547.
17. Engel P., Zhou L.J., Ord D.C., Sato S., Koller B., Tedder T.F. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity. 3:1995;39-50.
18. Fearon D.T., Carroll M.C. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19-CD21 complex. Annu. Rev. Immunol. 18:2000;393-422.
19. Fruman D.A., Snapper S.B., Yballe C.M., Davidson L., Yu J.Y., Alt F.W., Cantley L.C. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α Science. 283:1999;393-397.
20. Fujimoto M., Poe J.C., Jansen P.J., Sato S., Tedder T.F. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation. J. Immunol. 162:1999;7088-7094.
21. Fujimoto M., Y. Poe J.C., Jansen P.J., Lowell C.A., DeFranco A.L., Tedder T.F. CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification. Immunity. 13:2000;47-57.
22. 2+ responses: a role for Lyn sequestration in extinguishing negative regulation. J. Biol. Chem. 276:2001;44820-44827.
23. Hayakawa K., Hardy R.R., Herzenberg L.A. Peritoneal Ly-1 B cells: genetic control, autoantibody production, increased lambda light chain expression. Eur. J. Immunol. 16:1986;450-456.
24. 2+ mobilization is integrated by CD19 dephosphorylation. Immunity. 7:1997;49-58.
25. Kantor A.B., Herzenberg L.A. Origin of murine B cell lineages. Annu. Rev. Immunol. 11:1993;501-539.
26. Kiener P.A., Lioubin L., Rohrschneider L.R., Ledbetter J.A., Nadler S.G., Diegel M.L. Co-ligation of the antigen and Fc receptors gives rise to the selective modulation of intracellular signaling in B cells. J. Biol. Chem. 272:1997;3838-3844.
27. Krop I., De Fougerolles A.R., Hardy R.R., Allison M., Schlissel M.S., Fearon D.T. Self-renewal of B-1 lymphocytes is dependent on CD19. Eur. J. Immunol. 26:1996;238-242.
28. 2+. Eur. J. Immunol. 30:2000;1576-1586.
29. Matsumoto A.K., Kopicky-Burd J., Carter R.H., Tuveson D.A., Tedder T.F., Fearon D.T. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J. Exp. Med. 173:1991;55-64.
30. + B (B-1) cells and immunity, In: Snow. E.C. (Ed.), Handbook of B and T lymphocytes, Academic Press, New York, pp. 421-445.
31. Morris D.L., Rothstein T.L. Decreased surface IgM receptor-mediated activation of phospholipase Cγ 2 in B-1 lymphocytes. Int. Immunol. 6:1994;1011-1016.
32. Murakami M., Tsubata T., Okamoto M., Shimizu A., Kumagai S., Imura H., Honjo T. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature. 357:1992;77-80.
33. Muthukkumar S., Venkataraman C., Woods T., Bondada S. Activation of syk in an immature B cell line does not require Lyn activity. Mol. Immunol. 34:1997;865-875.
34. Muthusamy N., Baluyut A.R., Subbarao B. Differential regulation of surface Ig- and Lyb2-mediated B cell activation by cyclic AMP. I. Evidence for alternative regulation of signaling through two different receptors linked to phosphatidylinositol hydrolysis in murine B cells. J. Immunol. 147:1991;2483-2492.
35. O'Rourke L.M., Tooze R., Turner M., Sandoval D.M., Carter R.H., Tybulewicz V.L., Fearon D.T. CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. Immunity. 8:1998;635-645.
36. Pillai S. The chosen few? Positive selection and the generation of naive B lymphocytes. Immunity. 10:1999;493-502.
37. Rickert R.C., Rajewsky K., Roes J. Impairment of T cell-dependent B cell responses and B-1 cell development in CD19-deficient mice. Nature. 376:1995;352-355.
38. Sen G., Bikah G., Venkataraman C., Bondada S. Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells. Eur. J. Immunol. 29:1999;3319-3328.
39. Su I., Tarakhovsky A. B-1 cells: orthodox or conformist? Curr. Opin. Immunol. 12:2000;191-194.
40. Tarakhovsky A., Turner M., Schaal S., Mee P.J., Duddy L.P., Rajewsky K., Tybulewicz V.L. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature. 374:1995;467-470.
41. Tedder T.F., Inaoki M., Sato S. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity. 6:1997;107-118.
42. Tedford K., Nitschke L., Girkontaite I., Charlesworth A., Chan G., Sakk V., Barbacid M., Fischer K.D. Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signaling. Nat. Immunol. 2:2001;548-555.
43. Tooze R.M., Doody G.M., Fearon D.T. Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin. Immunity. 7:1997;59-67.
44. Tuveson D.A., Carter R.H., Soltoff S.P., Fearon D.T. CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science. 260:1993;986-989.
45. Van Noesel C.J.M., Lankester A.C., Van Schijndel G.M.W., Van Lier R.A.W. The CR2/CD19 complex on human B cells contains the Src-family kinase Lyn. Int. Immunol. 5:1993;699-705.
46. Venkataraman C., Lu P.-J., Buhl A.M., Chen C.-S., Cambier J.C., Bondada S. CD72 mediated B cell activation involves recruitment of CD19 and activation of phosphatidylinositol 3-kinase. Eur. J. Immunol. 28:1998a;3003-3016.
47. Venkataraman C., Muthusamy N., Muthukkumar S., Bondada S. Activation of Lyn, blk and btk but not syk in CD72 stimulated B lymphocytes. J. Immunol. 160:1998;3322-3329.
48. Wortis H.H., Berland R. Cutting edge commentary: origins of B-1 cells. J. Immunol. 166:2001;2163-2166.
49. Wu, H.J., Bondada, S., 2001. Positive and negative roles of CD72 in B cell function, Immunol. Res. 24.
50. Zhang R., Alt F.W., Davidson L., Orkin S.H., Swat W. Defective signalling through the T and B cell antigen receptors in lymphoid cells lacking the Vav proto-oncogene. Nature. 374:1995;470-473.